CRTC2 promotes paclitaxel resistance by inducing autophagy in ovarian cancer in part via the PI3K-AKT signaling axis

Background: Ovarian cancer is the most malignant gynecological disease, which seriously threatens female physical and mental health. Paclitaxel is a first-line chemotherapy drug in the clinical treatment of ovarian cancer, but drug resistance has become an important factor affecting the survival of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Chaoyang, Peng, Chen, Wang, Yilang, Lu, Shiyu, Yu, Xinli, He, Qian, He, Aiqin, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158520/
https://www.ncbi.nlm.nih.gov/pubmed/37151390
http://dx.doi.org/10.7150/jca.82233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158520/
https://www.ncbi.nlm.nih.gov/pubmed/37151390
http://dx.doi.org/10.7150/jca.82233

Ejemplares similares